InterMune (ITMN)

9.99 -0.31  -3.01%  May 17, 8:00PM
Add to Watchlists Create an Alert

InterMune Revenue Quarterly:

10.53M for March 31, 2013
View Full Chart

InterMune Revenue Quarterly Chart

    InterMune Historical Revenue Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 10.53M
    Dec. 31, 2012 8.222M
    Sept. 30, 2012 7.534M
    June 30, 2012 5.538M
    March 31, 2012 4.88M
    Dec. 31, 2011 2.66M
    Sept. 30, 2011 0.118M
    June 30, 2011 1.329M
    March 31, 2011 6.352M
    Dec. 31, 2010 221.62M
    Sept. 30, 2010 5.654M
    June 30, 2010 5.892M
    March 31, 2010 6.082M
    Dec. 31, 2009 6.611M
    Sept. 30, 2009 27.31M
    June 30, 2009 7.928M
    March 31, 2009 6.85M
    Dec. 31, 2008 7.401M
    Sept. 30, 2008 23.32M
    June 30, 2008 8.114M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Revenues

    Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

    While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
    Learn More

    Get data for

    ITMN Revenue Quarterly Benchmarks

    Companies
    Galena Biopharma 0.00
    AVEO Pharmaceuticals 0.323M
    Sarepta Therapeutics 7.336M

    ITMN Revenue Quarterly Rankings

    Overall 48th percentile
    3926 of 7593
    Sector 53rd percentile
    300 of 650 in Healthcare
    Industry 76th percentile
    56 of 237 in Biotechnology

    ITMN Revenue Quarterly Range, Past 5 Years

    Minimum 0.1180M Sep 2011
    Maximum 221.62M Dec 2010
    Average 18.70M